Ind-Swift Laboratories had a total income of Rs.255.75 crores during the period ended June 30, 2021, as compared to Rs 216.19 crores for the corresponding period last year. The total income for the period March 31, 2020, stood at Rs 229.11 crores.

The company has posted a net profit of Rs.18.80 crores for the period ended June 30, 2021, as against a net profit of Rs 4.57 crores for the corresponding period last year. The loss for the period ended March 31, 2021, was Rs 29.18 crores.

The company has reported EPS of Rs.3.18 for the period ended June 30, 2021, as compared to Rs 0.77 for the corresponding period last year. The EPS for the period ended June March 31, 2021, was Rs (4.94).

Earlier this month, Ind-Swift sold their Active Pharmaceuticals Ingredients (API), business to PI Industries on a slump sale at an agreed enterprise value of Rs 1,530 crores.